103 related articles for article (PubMed ID: 10892597)
1. Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen.
Sparidans RW; Hoetelmans RM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 2000 May; 742(1):185-92. PubMed ID: 10892597
[TBL] [Abstract][Full Text] [Related]
2. Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry.
Pereira AS; Kenney KB; Cohen MS; Eron JJ; Tidwell RR; Dunn JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):307-17. PubMed ID: 11824819
[TBL] [Abstract][Full Text] [Related]
3. [Simultaneous quantitative determination of amprenavir and indinavir in human plasma by high-performance liquid chromatography].
Laussine S; Roux A; Delhotal-Landes B; Flouvat B
Ann Biol Clin (Paris); 2001; 59(2):169-75. PubMed ID: 11282520
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
Yamada H; Kotaki H; Nakamura T; Iwamoto A
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):85-9. PubMed ID: 11393736
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy.
Gunawan S; Griswold MP; Kahn DG
J Chromatogr A; 2001 Apr; 914(1-2):1-4. PubMed ID: 11358202
[TBL] [Abstract][Full Text] [Related]
7. Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection.
Hoetelmans RM; van Essenberg M; Meenhorst PL; Mulder JW; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):235-41. PubMed ID: 9367213
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
van Heeswijk RP; Hoetelmans RM; Harms R; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):159-68. PubMed ID: 9869376
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Choi SO; Rezk NL; Kashuba AD
J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva.
Hoetelmans RM; van Essenberg M; Profijt M; Meenhorst PL; Mulder JW; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):119-26. PubMed ID: 9498678
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection.
Sparidans RW; Hoetelmans RM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 2001 Jan; 750(1):155-61. PubMed ID: 11204216
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatographic assay for the protease inhibitor atazanavir in plasma.
Sparidans RW; Dost F; Crommentuyn KM; Huitema AD; Schellens JH; Beijnen JH
Biomed Chromatogr; 2006 Jan; 20(1):72-6. PubMed ID: 15954163
[TBL] [Abstract][Full Text] [Related]
13. Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.
Chaudry NI; Eron JJ; Naderer OJ; Pereira AS; Wire MB; Fiscus SA; Kashuba AD
Clin Infect Dis; 2002 Sep; 35(6):760-2. PubMed ID: 12203175
[TBL] [Abstract][Full Text] [Related]
14. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Weller DR; Brundage RC; Balfour HH; Vezina HE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma.
Proust V; Toth K; Hulin A; Taburet AM; Gimenez F; Singlas E
J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):453-8. PubMed ID: 10901152
[TBL] [Abstract][Full Text] [Related]
16. Determination of amprenavir total and unbound concentrations in plasma by high-performance liquid chromatography and ultrafiltration.
Barrail A; Le Tiec C; Paci-Bonaventure S; Furlan V; Vincent I; Taburet AM
Ther Drug Monit; 2006 Feb; 28(1):89-94. PubMed ID: 16418700
[TBL] [Abstract][Full Text] [Related]
17. Bioanalysis of HIV protease inhibitors in samples from sanctuary sites.
Crommentuyn KM; Huitema AD; Beijnen JH
J Pharm Biomed Anal; 2005 Jun; 38(1):139-47. PubMed ID: 15907632
[TBL] [Abstract][Full Text] [Related]
18. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
19. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
ter Heine R; Alderden-Los CG; Rosing H; Hillebrand MJ; van Gorp EC; Huitema AD; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(15):2505-14. PubMed ID: 17610214
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
Kuschak D; Mauss S; Schmutz G; Gantke B
Clin Lab; 2001; 47(9-10):471-7. PubMed ID: 11596909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
